These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 837975)

  • 1. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against serotonin involvement in the tonic component of electrically induced convulsions and in carbamazepine anticonvulsant activity.
    Crunelli V; Bernasconi S; Samanin R
    Psychopharmacology (Berl); 1979; 66(1):79-85. PubMed ID: 120546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracisternal 6-hydroxydopamine on seizure susceptibility in rats.
    Browning RA; Maynert EW
    Eur J Pharmacol; 1978 Jul; 50(2):97-101. PubMed ID: 679982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selective depletions of brain monoamines.
    Quattrone A; Crunelli V; Samanin R
    Neuropharmacology; 1978 Aug; 17(8):643-7. PubMed ID: 692823
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effects of 6-hydroxydopamine on the clonic convulsions induced by electroshock and decapitation.
    Fukuda T; Araki Y; Suenaga N
    Neuropharmacology; 1975 Aug; 14(8):579-83. PubMed ID: 1178115
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitated aggression in the rat following 6-hydroxydopamine administration.
    Eichelman BS; Thoa NB; Ng KY
    Physiol Behav; 1972 Jan; 8(1):1-3. PubMed ID: 4677199
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of midbrain raphe lesion and of 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats.
    Cowan A; Ghezzi D; Samanin R
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):302-5. PubMed ID: 4851667
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbamazepine, phenytoin and phenobarbital do not influence brain catecholamine uptake, in vivo, in male rats.
    Quattrone A; Annunziato L; Aguglia U; Preziosi P
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):180-5. PubMed ID: 7305556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensified aggressivity of dominant male mice after the intraventricular administration of 6-hydroxydopamine].
    Serova LI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(3):513-8. PubMed ID: 3142159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.
    Taylor KM; Clark DW; Laverty R; Phelan EL
    Nat New Biol; 1972 Oct; 239(95):247-8. PubMed ID: 4507808
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+.
    Dailey JW; Reith ME; Yan QS; Li MY; Jobe PC
    Eur J Pharmacol; 1997 Jun; 328(2-3):153-62. PubMed ID: 9218697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of brain amines reverses blood pressure response to footshock in rat.
    Williams RB; Eichelman B; Ng LK
    Nat New Biol; 1972 Dec; 240(104):276-7. PubMed ID: 4512232
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
    Howard JL; Grant LD; Breese GR
    J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
    Fibiger HC; Mason ST
    Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.
    Mason ST; Corcoran ME
    J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.